Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 127

1.

Does the ATA Risk Stratification Apply to Patients with Papillary Thyroid Microcarcinoma?

Stefanova DI, Bose A, Ullmann TM, Limberg JN, Finnerty BM, Zarnegar R, Fahey TJ 3rd, Beninato T.

World J Surg. 2019 Oct 11. doi: 10.1007/s00268-019-05215-4. [Epub ahead of print]

PMID:
31605172
2.

Does Aggressive Variant Histology Without Invasive Features Predict Overall Survival in Papillary Thyroid Cancer?: A National Cancer Database Analysis.

Limberg J, Ullmann TM, Stefanova D, Buicko JL, Finnerty BM, Zarnegar R, Fahey TJ 3rd, Beninato T.

Ann Surg. 2019 Oct 9. doi: 10.1097/SLA.0000000000003632. [Epub ahead of print]

PMID:
31599802
3.

Dual inhibition of BRAF and MEK increases expression of sodium iodide symporter in patient-derived papillary thyroid cancer cells in vitro.

Ullmann TM, Liang H, Moore MD, Al-Jamed I, Gray KD, Limberg J, Stefanova D, Buicko JL, Finnerty B, Beninato T, Zarnegar R, Min IM, Fahey TJ 3rd.

Surgery. 2019 Oct 1. pii: S0039-6060(19)30576-8. doi: 10.1016/j.surg.2019.04.076. [Epub ahead of print]

PMID:
31585718
4.

Insurance Status Is Associated with Extent of Treatment for Patients with Papillary Thyroid Carcinoma.

Ullmann TM, Gray KD, Limberg J, Stefanova D, Moore MD, Buicko J, Finnerty B, Zarnegar R, Fahey TJ 3rd, Beninato T.

Thyroid. 2019 Oct 8. doi: 10.1089/thy.2019.0245. [Epub ahead of print]

PMID:
31502525
5.

Prognostic Characteristics of Primary Squamous Cell Carcinoma of the Thyroid: A National Cancer Database Analysis.

Limberg J, Ullmann TM, Stefanova D, Finnerty BM, Beninato T, Fahey TJ 3rd, Zarnegar R.

World J Surg. 2019 Aug 9. doi: 10.1007/s00268-019-05098-5. [Epub ahead of print]

PMID:
31399796
6.

Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy.

Vedvyas Y, McCloskey JE, Yang Y, Min IM, Fahey TJ, Zarnegar R, Hsu YS, Hsu JM, Besien KV, Gaudet I, Law P, Kim NJ, Hofe EV, Jin MM.

Sci Rep. 2019 Jul 23;9(1):10634. doi: 10.1038/s41598-019-46938-7.

7.

Treatment Utilization and Socioeconomic Disparities in the Surgical Management of Gastroparesis.

Gray KD, Ullmann TM, Elmously A, Beninato T, Fahey TJ 3rd, Pomp A, Zarnegar R, Afaneh C.

J Gastrointest Surg. 2019 Jul 10. doi: 10.1007/s11605-019-04294-x. [Epub ahead of print]

PMID:
31292891
8.

Validation of the Aldosteronoma Resolution Score Within Current Clinical Practice.

Vorselaars WMCM, van Beek DJ, Postma EL, Spiering W, Borel Rinkes IHM, Valk GD, Vriens MR; International CONNsortium Study Group.

World J Surg. 2019 Oct;43(10):2459-2468. doi: 10.1007/s00268-019-05074-z. Erratum in: World J Surg. 2019 Sep 5;:.

PMID:
31270571
9.

Conversion During Laparoscopic Adrenalectomy for Pheochromocytoma: A Cohort Study in 244 Patients.

Schweitzer ML, Nguyen-Thi PL, Mirallie E, Vriens M, Raffaelli M, Klein M, Zarnegar R, Brunaud L.

J Surg Res. 2019 Nov;243:309-315. doi: 10.1016/j.jss.2019.05.042. Epub 2019 Jun 26.

PMID:
31254904
10.

The 2015 American Thyroid Association guidelines are associated with an increasing rate of hemithyroidectomy for thyroid cancer.

Ullmann TM, Gray KD, Stefanova D, Limberg J, Buicko JL, Finnerty B, Zarnegar R, Fahey TJ 3rd, Beninato T.

Surgery. 2019 Sep;166(3):349-355. doi: 10.1016/j.surg.2019.03.002. Epub 2019 May 2.

PMID:
31056200
11.

Clinical outcomes after surgery for primary aldosteronism: Evaluation of the PASO-investigators' consensus criteria within a worldwide cohort of patients.

Vorselaars WMCM, van Beek DJ, Postma EL, Spiering W, Borel Rinkes IHM, Valk GD, Vriens MR; International CONNsortium study group.

Surgery. 2019 Jul;166(1):61-68. doi: 10.1016/j.surg.2019.01.031. Epub 2019 May 1.

PMID:
31053245
12.

Laparoscopic Adrenalectomy Has the Same Operative Risk as Routine Laparoscopic Cholecystectomy.

Limberg J, Ullmann TM, Gray KD, Stefanova D, Zarnegar R, Li J, Fahey TJ 3rd, Beninato T.

J Surg Res. 2019 Sep;241:228-234. doi: 10.1016/j.jss.2019.03.042. Epub 2019 Apr 28.

PMID:
31029933
13.

Clinical Outcomes After Unilateral Adrenalectomy for Primary Aldosteronism.

Vorselaars WMCM, Nell S, Postma EL, Zarnegar R, Drake FT, Duh QY, Talutis SD, McAneny DB, McManus C, Lee JA, Grant SB, Grogan RH, Romero Arenas MA, Perrier ND, Peipert BJ, Mongelli MN, Castelino T, Mitmaker EJ, Parente DN, Pasternak JD, Engelsman AF, Sywak M, D'Amato G, Raffaelli M, Schuermans V, Bouvy ND, Eker HH, Bonjer HJ, Vaarzon Morel NM, Nieveen van Dijkum EJM, Vrielink OM, Kruijff S, Spiering W, Borel Rinkes IHM, Valk GD, Vriens MR; International CONNsortium study group.

JAMA Surg. 2019 Apr 1;154(4):e185842. doi: 10.1001/jamasurg.2018.5842. Epub 2019 Apr 17.

PMID:
30810749
14.

UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors.

Finnerty BM, Moore M, Verma A, Aronova A, Huang S, Edwards DP, Chen Z, Seandel M, Scognamiglio T, Du N, Elemento O, Zarnegar R, Min IM, Fahey TJ.

Endocr Relat Cancer. 2019 Apr 1;26(4):411-423. doi: 10.1530/ERC-18-0507. Epub 2019 Jan 1.

PMID:
30689542
15.

Current controversies and future directions in the diagnosis and management of differentiated thyroid cancers.

Ullmann TM, Gray KD, Moore MD, Zarnegar R, Fahey TJ 3rd.

Gland Surg. 2018 Oct;7(5):473-486. doi: 10.21037/gs.2017.09.08. Review.

16.

ASO Author Reflections: Outcomes of Gastroesophageal Neuroendocrine Tumors.

Gray KD, Zarnegar R.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):868-869. doi: 10.1245/s10434-018-6902-y. Epub 2018 Nov 12. No abstract available.

PMID:
30421041
17.

Parathyroidectomy versus Cinacalcet in the Management of Tertiary Hyperparathyroidism: Surgery Improves Renal Transplant Allograft Survival.

Finnerty BM, Chan TW, Jones G, Khader T, Moore M, Gray KD, Beninato T, Watkins AC, Zarnegar R, Fahey TJ 3rd.

Surgery. 2019 Jan;165(1):129-134. doi: 10.1016/j.surg.2018.04.090. Epub 2018 Nov 8.

PMID:
30415867
18.

Expression of programmed death ligand 1 and 2 in adrenocortical cancer tissues: An exploratory study.

Tierney JF, Vogle A, Poirier J, Min IM, Finnerty B, Zarnegar R, Pappas SG, Scognamiglio T, Ghai R, Gattuso P, Fahey TJ 3rd, Keutgen XM.

Surgery. 2019 Jan;165(1):196-201. doi: 10.1016/j.surg.2018.04.086. Epub 2018 Nov 7.

PMID:
30413322
19.

CHL1 expression differentiates Hürthle cell carcinoma from benign Hürthle cell nodules.

Li W, Xia S, Aronova A, Min IM, Verma A, Scognamiglio T, Gray KD, Ullmann TM, Liang H, Moore MD, Elemento O, Zarnegar R, Fahey TJ.

J Surg Oncol. 2018 Nov;118(6):1042-1049. doi: 10.1002/jso.25214. Epub 2018 Oct 12.

PMID:
30311656
20.

High-dose radioactive iodine therapy is associated with decreased risk of recurrence in high-risk papillary thyroid cancer.

Gray KD, Bannani S, Caillard C, Amanat S, Ullmann TM, Romanov P, Brunaud L, Beninato T, Fahey TJ 3rd, Mirallie E, Zarnegar R.

Surgery. 2019 Jan;165(1):37-43. doi: 10.1016/j.surg.2018.04.059. Epub 2018 Sep 28.

PMID:
30274732

Supplemental Content

Loading ...
Support Center